• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of Fast Track designation requests granted

Dictionary: Fast track is an expedited drug development and review program for new drugs or biologics intended to treat serious or life-threatening conditions that demonstrate the potential to address unmet medical need.

Information is current as of March 31, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetNumber
Oct 2013N/A10
Nov 2013N/A6
Dec 2013N/A8
Jan 2014N/A6
Feb 2014N/A10
Mar 2014N/A5
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 45

Footnotes

  • CDER created new measures and began collecting data in July 2012. Therefore, FY12 will only include 3 months of data.

Number of applications approved under Accelerated Approval

Dictionary: Accelerated Approval is a regulatory pathway that allows for approval of drugs intended to treat serious or life-threatening diseases and that provide meaningful therapeutic benefit to patients over existing therapies, based on the use of surrogate endpoints reasonably likely to predict clinical benefits or a clinical endpoint other than survival or irreversible morbidity. (See also 21 CFR 314 Subpart H and 601 Subpart E)

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetNumber
Oct 2013N/A0
Nov 2013N/A1
Dec 2013N/A0
Jan 2014N/A0
Feb 2014N/A2
Mar 2014N/A0
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 3

Number of First Generics approved

Dictionary: The first time that a particular drug is approved in generic form.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetNumber
Oct 2013N/A5
Nov 2013N/A16
Dec 2013N/A10
Jan 2014N/A16
Feb 2014N/A12
Mar 2014N/A7
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 66

Number of orphan drugs addressing rare diseases approved

Dictionary: Orphan drugs are products intended for the safe and effective treatment of rare diseases/disorders that affect fewer than 200,000 U.S. patients.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetNumber
Oct 2013N/A2
Nov 2013N/A3
Dec 2013N/A1
Jan 2014N/A3
Feb 2014N/A4
Mar 2014N/A2
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 15

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.